In millions, except per share items | Sep-30-15 | Jun-30-15 | Mar-31-15 | Dec-31-14 | Sep-30-14 | Jun-30-14 | Mar-31-14 | Dec-31-13 |
| 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
Interest income on loans | 17.0 | 16.8 | 16.9 | 17.0 | 17.6 | 17.7 | 18.5 | 19.3 |
Total interest income | 19.3 | 19.5 | 19.8 | 20.0 | 20.3 | 19.9 | 20.1 | 20.6 |
Interest expense: |
Interest on deposits | 2.3 | 2.3 | 2.4 | 2.4 | 2.4 | 2.5 | 2.6 | 2.8 |
Interest on borrowings | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.9 |
| 2.3 | 2.3 | 2.4 | 2.4 | 2.4 | 2.5 | 2.6 | 2.8 |
Net interest income | 21.6 | 21.8 | 22.1 | 22.3 | 22.7 | 22.4 | 22.8 | 23.4 |
Provision for loan losses | | -1.4 | | | | -0.7 | | |
Net interest income after provision for loan losses | 23.0 | 23.2 | 22.8 | 23.1 | 23.4 | 23.1 | 22.8 | 23.1 |
Deposit and loan fees | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | 0.8 |
Gain on sale of investments, net | | | | | | | | -1.8 |
Other non-interest income | 3.3 | 4.2 | 4.5 | 4.3 | 3.0 | 2.5 | 2.9 | 4.1 |
Total non-interest income | 4.0 | 4.9 | 5.2 | 5.0 | 1.9 | 1.4 | 1.9 | 3.1 |
Non-interest expenses | 20.0 | 20.5 | 20.7 | 21.8 | 21.6 | 21.7 | 22.6 | 22.4 |
Pre-tax income before non-recurring items | 3.5 | 3.7 | 2.1 | 1.0 | -1.7 | -3.8 | -8.7 | -8.5 |
Non-recurring items | 0.9 | 0.6 | | | | | | |
Pre-tax income | 2.5 | 3.1 | 2.1 | 1.0 | -1.7 | -3.8 | -8.7 | -8.5 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 0.4 | 0.4 | 0.4 |
Tax rate | -0.5% | -0.4% | -0.6% | | -21.7% | -9.8% | -4.3% | |
Net income | 2.5 | 3.1 | 2.1 | 1.0 | -2.1 | -4.2 | -9.1 | -8.8 |
Net margin | 9.8% | 11.4% | 7.5% | 3.6% | -8.4% | -17.3% | -36.4% | -33.1% |
|
Basic EPS | $0.38 | $0.46 | $0.31 | $0.15 | ($0.31) | ($0.63) | ($1.36) | ($1.33) |
Diluted EPS | $0.38 | $0.46 | $0.31 | $0.15 | ($0.31) | ($0.63) | ($1.36) | ($1.33) |
|
Shares outstanding (basic) | 6.7 | 6.7 | 6.7 | 6.7 | 6.7 | 6.7 | 6.7 | 6.6 |
Shares outstanding (diluted) | 6.7 | 6.7 | 6.7 | 6.7 | 6.7 | 6.7 | 6.7 | 6.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |